Intermittent Claudication Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical and Radiological Outcomes Following Insertion of a Novel Removable Percutaneous Interspinous Process Spacer: an Initial Experience.
Conditions: Degenerative Lumbar Spinal Stenosis; Neurologic Intermittent Claudication Intervention: Other: percutaneous removable interspinous process Sponsor: Centre Hospitalier Universitaire de Nice Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 24, 2022 Category: Research Source Type: clinical trials

Bioequivalence Study of Once Daily PMR Compared to Twice Daily Cilostazol IR Tablets in Healthy Volunteers
Condition: Intermittent Claudication Interventions: Drug: Cilostazol 100 mg; Drug: PMR 135 mg Sponsor: Genovate Biotechnology Co., Ltd., Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 14, 2022 Category: Research Source Type: clinical trials

CRUSH PAD: Real-world Outcomes Following Use of the Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions
Conditions: Femoral Arterial Calcification; Peripheral Arterial Disease; Claudication; Critical Limb Ischemia Intervention: Device: Shockwave Intravascular Lithotripsy (IVL) Sponsors: Yale University; Shockwave Medical, Inc.; University Hospitals Cleveland Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2021 Category: Research Source Type: clinical trials